Position in TMO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,150,215
+$2,750,395 QoQ
Shares Held
6,409
+828.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026AXQ CAPITAL, LP holds $11,683,566 across 11 Diagnostics & Research names. TMO ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
6,409 | $3,150,215 | |
| 2 | DHR |
Danaher Corp /De/
|
10,354 | $1,963,118 | |
| 3 | A |
Agilent Technologies, Inc.
|
16,042 | $1,828,467 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
2,960 | $1,663,194 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
1,098 | $1,384,797 | |
| 6 | QGEN |
Qiagen N.V.
|
23,227 | $930,009 | |
| 7 | GRAL |
GRAIL, Inc.
|
6,609 | $341,553 | |
| 8 | MYGN |
Myriad Genetics Inc
|
45,127 | $203,071 |
All Filings in TMO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,150,215 | 6,409 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $399,820 | 690 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $2,266,926 | 5,591 | Shares | Sole | 2025-08-12 | |
| 2024-09-30 | $1,637,973 | 2,648 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,877,083 | 7,011 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,859,872 | 3,200 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $743,106 | 1,400 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $573,925 | 1,100 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||